Posted by Michael Wonder on 05 Aug 2016
TGA publishes AusPAR for Xiaflex
5 August 2016 - The TGA has published an AusPAR for Actelion's Xiaflex (collagenase clostridium histolyticum).
The TGA approvex Xiaflex on 16 March 2016 for the treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.
